Hypertriglyceridemia in acute pancreatitis: report of three cases with their treatments
DOI:
https://doi.org/10.22529/me.2022.7(3)07Keywords:
Pancreatitis, hypertriglyceridemia, insulin therapy, plasmapheresisAbstract
Acute pancreatitis (AP) is an acute and reversible inflammatory process of the pancreas. AP is associated
with multiple etiologies, including hypertriglyceridemia which is responsible of 1% to 14% of all cases of
AP. The risk of AP associated with hypertriglyceridemia increases directly proportionally to serum
triglyceride levels, especially when exceeding 500 mg / dL.
It is important to keep this etiology in mind as it is associated with a poor prognosis.
Presenting in the following clinical cases, two men and one woman, young people between 35 and 41 years
of age.
Its importance lies in the fact that there are three clinical syndromes caused by hypertriglyceridemia, but
with different antecedents, clinical evolution and treatment. Currently, various publications agree that the
increase in prevalent diseases: hypertension, diabetes and obesity, are related to familial or non-familial
hypertriglyceridemia and this will undoubtedly modify the percentage of BP due to a serum level of
triglycerides as well as the increase in cirrhosis due to NASH.
The different evolutions and treatments used with their responses are observed according to the triglyceride
value, taking into account that there is no standard treatment for the management of the disease due to its
infrequency 2. Therefore, cases will be shown to add to the evidence in this treatment. In addition, the
prolongation of hospitalizations can be observed due to complications secondary to this disease.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Methodo Investigación Aplicada a las Ciencias Biológicas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.